Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 77 (KRT77) is a type II intermediate filament protein encoded by the KRT77 gene on chromosome 12q13 and is part of the cytokeratin family responsible for imparting structural integrity to epithelial cells[1][2][3][4][7]. KRT77 is specifically expressed in the skin, especially in the granular layer of epidermal keratinocytes, and is absent from acral keratinocytes[2][3]. Its expression is temporally coordinated during epidermal development alongside key differentiation and barrier-forming markers[1]. Aberrant regulation or upregulation of KRT77 has been observed in conditions with disrupted epidermal differentiation, suggesting its value as a marker for immature keratinocytes[1]. KRT77 is associated with several skin and epithelial pathologies, but there are currently no known drugs directly targeting this protein[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 77 (KRT77).